Mr. Jim Breslin:

The previous appointment was Dr. Susan O'Reilly. Dr. O'Reilly was in Dr. Coffey's role, which was head of the national cancer control programme within the HSE. The view that is being taken is that the relationship has to be a very good one and that for the hunting down of information the National Cancer Registry has to do in hospitals and all kinds of healthcare settings, it needs to have the support of a healthcare provider to accomplish what is a very rich dataset and one of the most renowned cancer registries. Allowing that cancer expertise and cancer service delivery to be part of the board is an important part of the cancer registry success.